✨ Free AI Report
Advanced Biomed Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Advanced Biomed Inc.
Company Research

Advanced Biomed Inc.: Business Overview, Financials & Competitive Analysis

Advanced Biomed Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Early-stage precision oncology diagnostics platform with integrated Asia-Pacific clinical operations, dependent on scaling production and validating clinical adoption in competitive circulating tumor cell detection market. Advanced Biomed operates in a high-growth precision diagnostics sector with differentiated microfluidic technology and integrated clinical operations. However, the company is newly public (March.

What is Advanced Biomed Inc.'s industry? Advanced Biomed Inc. (null) operates in Personalized Medicine. AskCyborg classifies Advanced Biomed Inc. under Personalized Medicine in its company registry.

Advanced Biomed Inc. is an investment holding company engaged in research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment. The company went public on NAS...

5/ 10Mixed

Cyborg Score thesis

Early-stage precision oncology diagnostics platform with integrated Asia-Pacific clinical operations, dependent on scaling...

Read the full analyst-debate transcript →
Industry Personalized Medicine
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Advanced Biomed Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Advanced Biomed Inc.

AskCyborg analysts argue the bull and bear cases for Advanced Biomed Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Advanced Biomed Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Advanced Biomed Inc. Overview

Pro stress-test →

Advanced Biomed Inc. is an investment holding company engaged in research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment. The company went public on NASDAQ in March 2025, raising $6.56 million from its initial public offering, positioning itself in the precision cancer diagnostics market through innovative circulating tumor cell detection technology.

Strategic Profile

Pro stress-test →

Since 2014, Advanced Biomed has focused on integrating multiple interdisciplinary technologies to build its microfluidic technology platform, aiming to provide rapid and affordable assay products and services to cancer patients. The company also establishes and operates medical clinics in China, creating a vertically integrated model combining device manufacturing with clinical service delivery for oncology applications.

Competitive Landscape

Pro stress-test →

Advanced Biomed competes in the precision oncology diagnostics and circulating tumor cell (CTC) detection market against established medical device and diagnostics companies. Key competitors include larger, better-capitalized entities with broader portfolios in liquid biopsy and cancer diagnostics, though Advanced Biomed differentiates through its integrated microfluidic platform and clinically owned testing infrastructure in Asia-Pacific.

Industry Context

Advanced Biomed Inc. operates in Personalized Medicine.

Key facts

Founded: 2014 · Headquarters: Tainan, Taiwan · Revenue: Estimated less than $10M annually (early-stage post-IPO, private data not available)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Advanced Biomed Inc..

  • IPO closed in March 2025 with $6.56 million in gross proceeds; company trades on NASDAQ under ticker ADVB with microfluidic biochip technology addressing circulating tumor cell detection and cancer diagnostics.
  • Device portfolio includes A+Pre (automated sample prep), AC-1000 (rare cell/CTC enrichment), A+CellScan (analyzer with immunostaining), and A+SCDrop (single-cell capture); multiple immunochromogenic kits for epithelial, mesenchymal, and macrophage identification in tumor cells.

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2025IPO closing on NASDAQ Capital Market with 1.64 million shares at $4.00/share for $6.56 million gross proceeds
  • August 2021Establishment of Advanced Biomed HK Limited subsidiary in Hong Kong to facilitate market development and distribution in People's Republic of China
Get alerted when Advanced Biomed Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

QIAGENGlobal provider of molecular diagnostics and liquid biopsy solutions→IlluminaGenomics and liquid biopsy platforms for cancer detection and monitoring→Bio-Rad LaboratoriesClinical diagnostics and life science research products including CTC isolation→

Compare Advanced Biomed Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Advanced Biomed Inc. operates in Personalized Medicine. See how the rest of the sector scores on the Cyborg framework.

Browse Personalized Medicine research →
NEW · MCP server

Ask your AI assistant about Advanced Biomed Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Advanced Biomed Inc. and its top competitor on Cyborg Score”
“What did Advanced Biomed Inc. do this quarter?”
“Is Advanced Biomed Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Advanced Biomed Inc. do?+
Advanced Biomed Inc. is an investment holding company engaged in research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment. The company went public on NAS...
What is Advanced Biomed Inc.'s Cyborg Score?+
Advanced Biomed Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Advanced Biomed Inc.'s main competitors?+
Named competitors include QIAGEN, Illumina, Bio-Rad Laboratories. The full competitive landscape is in the AskCyborg report.
How can I get the full Advanced Biomed Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Advanced Biomed Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Advanced Biomed Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Personalized Medicine research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Illumina, Inc.